In vitro inhibition of mastitis pathogens by bacteriocin RN 86 produced by an indigenous Lactobacillus casei isolate

Journal of Applied Sciences

Volumn 6, Issue 12, 2006, Pages 2629-2634

  Mojgani, Naheed ^a   Ashtiani, Mehdi Perveen ^a  

^a RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

Author keywords

Antibiotics; Bactericidal; Bacteriocins; Bovine mastitis; In vitro; L. casei; Teat seals

Indexed keywords

BACTERICIDAL; BACTERIOCINS; BOVINE MASTITIS; IN-VITRO; L. CASEI;

ANTIBIOTICS; BACTERIA; CELLS; CYTOLOGY; ENZYME INHIBITION; MAMMALS; PEPTIDES; PURIFICATION;

DISEASES;

EID: 33845239178     PISSN: 18125654     EISSN: 18125662     Source Type: Journal    
DOI: 10.3923/jas.2006.2629.2634     Document Type: Article

References (23)

1. Broadbent, J.R., C. Chou, K. Gillies and J.K. Kondo, 1989. Nisin inhibits several gram-positive, mastitis-causing pathogens. J. Dairy Sci., 72:3342-3345
2. Cleveland, J., T.J. Montville and I.F. Nes, 2001. Bacteriocins: Safe, natural antimicrobials for food preservation. Intl. J. Food Microbiol., 71: 1-20
3. Coakley, M., G.F. Fitzgerald and R.P. Ross, 1997. Application and evaluation of the phage resistance- and bacteriocin-encoding plasmid pMRC01 for the improvement of dairy starter cultures. Applied Environ. Microbiol., 63: 1434-1440.
4. Craven, N., 1987. Efficacy and financial value of antibiotic treatment of bovine clinical mastitis during lactation a review. Br. Vet. J., 143: 412-422.
5. Delves-Broughton, J., 1990. Nisin and its uses as a food preservative. Food Technol., 44: 100-112.
6. Giacometti, A., O. Cirioni and M.S. Del Prete, 2000. Combination studies between polycationic peptides and clinically used antibiotics against gram positive and gram negative bacteria. Peptides, 21: 1155-1160.
7. Guerra, N.P and L.P. Castro, 2002. Production of bacteriocins from lactococcus lactis CECT 539 and Pediococcus acidilactici NRRL B-5627 using mussel processing wastes. Biotech. Applied Biochem., 36: 119-125.
8. Hancock, R.E. and D. Chapple, 1999. Peptide antibiotics. Antimicrobial Agent and Chemo., 43: 1317-1323.
9. Ingham, A., M. Ford, R.J. Moore and M. Tizard, 2003. The bacteriocin piscicolin 126 retains antilisterial activity in vivo. J. Antimicrob. Chemother., 51: 1365-1371.
10. Mayr-Hartings, A., A.J. Hedges and R.C.W. Berkeley, 1992. Methods for studying bacteriocins. Meth. Microbiol., 7: 315-422.
11. McAuliffe, O., M.P. Ryan, R.P. Ross, C. Hill, P. Breeuwer and T. Abee, 1998. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Applied Environ. Microbiol., 64: 439-445
12. Meaney, W.J., 1977. Effect of dry period teat seal on bovine udder infection. Ir. J. Agric. Res., 16: 293-299.
13. Meaney, W.J., D.P. Twomey, Flynn. C. Hill and R.P. Ross, 2001. The use of a bismuth based teat seal and the bacteriocin lacticin 3147 to prevent dry period mastitis in dairy cows. Proc. British Mastitis Conference, Garstang, pp: 293-299.
14. Minahk, C.J., F. Dupuy and R.D. Morero, 2004. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35. J. Antimicrobiol. Chemother., 53: 240-246.
15. Morgan, S.M., P.M. O'Connor, P.D. Cotter, R.P. Ross and C. Hill. 2006. Sequential Actions of the Two Component Peptides of the Lantibiotic Lacticin 3147 Explain Its Antimicrobial Activity at Nanomolar Concentrations. Antimicrobial Agents. Chemother., 49: 2606-2611.
16. Oldham, E.R. and M.J. Daley, 1991. Lysostaphin: Use of a recombinant bactericidal enzyme as mastitis therapeutic. J. Dairy Sci., 74: 4175-4182.
17. Ryan, M.P., R.W. Jack, M. Josten, H.G. Sahl, G. Jung, R.P. Ross and C. Hill, 1999. Extensive Post-translational Modification, Including Serine to D-Alanine Conversion, in the two-component lantibiotic, lacticin 3147. J. Biol. Chem., 274: 37544-37550.
18. Schagger, H. and G. Von Jagow, 1987. Tricine SDS-PAGE for the separation of proteins in the range from 1 to 100 KDa. Anal. Biochem., 166: 368-379.
19. Sears, P.M., D.J. Wilson and R.N. Gonzalez, 1992. The potential role of antimicrobial proteins in the treatment of bovine mastitis. In Proceed 17th World Buiatrics Congress and the 25 American Association of Bovine Practitioners Conference, 2: 138-142.
20. Sears, P.M., J. Peele, M. Lassauzet and P. Blackburn, 1995. Use of antimicrobial proteins in the treatment of bovine mastitis. In Pro. 3rd Intl. Mastitis Seminar, pp: 17-18.
21. Toba, T., E. Yoshioka and I. Takatoshi, 1991. Lacticin, a bacteriocin produced by L. delbrueckie. Let. Applied Microbiol., 12: 43-45.
22. Van Veen, H., A. Margolles and M. Putman, 1999. Multidrug resistance in lactic acid bacteria: Molecular mechanisms and clinical relevance. Antonie van Leeuwenhoek 76: 347-352.
23. Wirawan, R.E., N.A., Klesse, R.W. Jack and J.R. Tagg, 2006. Molecular and Genetic Characterization of a Novel Nisin Variant Produced by Streptococcus uberis. Applied Environ. Microbiol., 72: 1148-1156.